Episode of #Breakpoints! Curious about controversies in the management of HAP VAP? Let's clear the air! Check out this infographic from @littlebugdrug and @moore_wjustin and listen along as Drs. @dblake096, @owenralb, The prevalence, presentation and outcome of colistin susceptible only Acinetobacter Baumannii associated pneumonia in intensive care unit: a multicenter observational study Scientific Reports HCAP is out New IDSA Guidelines for HAP and VAP JournalFeed Cost effectiveness Comparison of Ceftazidime Avibactam Versus Meropenem in the Empirical Treatment of Hospital acquired Pneumonia, Including Ventilator associated Pneumonia, in Italy ScienceDirect Hospital Acquired Pneumonia: Causes, Treatment & P ChatSlide